South State Corp Abbott Laboratories Transaction History

South State Corp

$1.52 Billion
Q4 2024

A detailed history of South State Corp transactions in Abbott Laboratories stock. As of the latest transaction made, South State Corp holds 50,295 shares of ABT stock, worth $6.57 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

50,295

Previous 51,618 2.56%

Holding current value

$6.57 Million

Previous $5.88 Million 3.33%

% of portfolio

0.37%

Previous 0.41%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$111.93 - $119.39 $148,083 - $157,952	-1,323 Reduced 2.56%	50,295 $5.69 Million
Q3 2024 Nov 08, 2024	BUY	$100.07 - $118.13 $46,332 - $54,694	463 Added 0.91%	51,618 $5.88 Million
Q2 2024 Aug 02, 2024	BUY	$100.73 - $112.44 $38,881 - $43,401	386 Added 0.76%	51,155 $5.32 Million
Q1 2024 May 06, 2024	BUY	$109.52 - $120.96 $270,623 - $298,892	2,471 Added 5.12%	50,769 $5.77 Million
Q4 2023 Feb 06, 2024	BUY	$90.19 - $110.4 $2.78 Million - $3.4 Million	30,815 Added 176.26%	48,298 $5.32 Million
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $2.91 Million - $3.49 Million	-30,452 Reduced 63.53%	17,483 $1.69 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $189,365 - $210,992	-1,879 Reduced 3.77%	47,935 $5.23 Million
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $286,027 - $336,671	-2,953 Reduced 5.6%	49,814 $5.04 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $5,608 - $6,579	-59 Reduced 0.11%	52,767 $5.79 Million
Q3 2022 Nov 07, 2022	SELL	$96.76 - $112.03 $131,303 - $152,024	-1,357 Reduced 2.5%	52,826 $5.11 Million
Q2 2022 Aug 05, 2022	BUY	$102.07 - $123.37 $171,069 - $206,768	1,676 Added 3.19%	54,183 $5.89 Million
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $429,741 - $524,041	3,769 Added 7.73%	52,507 $6.22 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $80,062 - $98,031	693 Added 1.44%	48,738 $6.86 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $18,432 - $20,391	-158 Reduced 0.33%	48,045 $5.68 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $45,066 - $53,049	-426 Reduced 0.88%	48,203 $5.59 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $3.54 Million - $4.18 Million	32,559 Added 202.61%	48,629 $5.83 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $3.79 Million - $4.13 Million	-36,081 Reduced 69.19%	16,070 $1.76 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $202,707 - $246,173	2,212 Added 4.43%	52,151 $5.68 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $98,239 - $125,734	1,283 Added 2.64%	49,939 $4.54 Million
Q1 2020 May 04, 2020	SELL	$62.82 - $91.86 $314,225 - $459,483	-5,002 Reduced 9.32%	48,656 $3.82 Million
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $61,630 - $68,609	785 Added 1.48%	53,658 $4.66 Million
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $419,020 - $454,348	-5,120 Reduced 8.83%	52,873 $4.42 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $499,738 - $582,845	-6,857 Reduced 10.57%	57,993 $4.88 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $27,812 - $33,625	-420 Reduced 0.64%	64,850 $5.18 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $282,694 - $320,252	-4,312 Reduced 6.2%	65,270 $4.72 Million
Q3 2018 Nov 08, 2018	BUY	$60.81 - $73.36 $10,884 - $13,131	179 Added 0.26%	69,582 $5.1 Million
Q2 2018 Aug 03, 2018	SELL	$57.57 - $63.54 $138,340 - $152,686	-2,403 Reduced 3.35%	69,403 $4.23 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $208,705 - $235,966	-3,709 Reduced 4.91%	71,806 $4.3 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $525,956 - $563,091	9,798 Added 14.91%	75,515 $4.31 Million
Q3 2017 Nov 09, 2017	SELL	$48.06 - $53.64 $42,773 - $47,739	-890 Reduced 1.34%	65,717 $3.51 Million
Q2 2017 Aug 10, 2017	BUY	N/A	66,607	66,607 $3.24 Million

Others Institutions Holding ABT

# of Institutions

3,303

Shares Held

1.34B

Call Options Held

9.84M

Put Options Held

8.59M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.

Account